Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Oxford Immunotec Global PLC gives Q3 2014 revenue guidance below analysts' estimates; raises low end of prior FY 2014 revenue guidance

Tuesday, 5 Aug 2014 07:00am EDT 

Oxford Immunotec Global PLC:Expect to report revenue of between $12.4 and $12.9 million for Q3 2014, and between $48 and $50 million for FY 2014.Q3 2014 revenue of $13.4 million - Thomson Reuters I/B/E/S.FY 2014 revenue of $50 million - Thomson Reuters I/B/E/S. 

Company Quote

-0.07 -0.50%
27 Feb 2015